The Lancet Oncology was launched in September, 2000, as a lively and informative monthly journal covering international issues relevant to clinical cancer specialists worldwide. The journal is now the world-leading clinical oncology periodical publishing high-quality, peer-reviewed research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academic centres). Content covers topics that advance clinical practice, challenge the status quo, advocate change in health policy, and tackle issues related to global oncology. Much of the journal’s articles are published Online First for enhanced timeliness prior to print publication. Uniquely, all original research is peer-reviewed via a fast-track service, and successful papers are published within 8 weeks of submission. The journal also regularly features podcasts, video, infographics, and curated web content.

Publisher
Elsevier
Website
http://www.thelancet.com/journals/lanonc/issue/current
Impact factor
33.9 (2016)

Some content from Wikipedia, licensed under CC BY-SA

Duke University pays $112M to settle faked-research lawsuit

Duke University will pay $112 million to settle a whistleblower lawsuit after federal prosecutors said a research technician's fake data landed millions of dollars in federal grants, the school and the government said Monday.

Removing environmental pollutants from raw meat

Six months ago, the International Agency for Research on Cancer associated consumption of red meat and processed meat to cancer risk. However, in its analysis, it made no reference to some carcinogenic environmental pollutants ...

A new technology to track down air pollutant effects

Did you ever see pollution level indicators displayed in big European cities? The EXPOSOMICS project is looking to make them obsolete. Not only will their technology determine the exact impact of pollutant exposure on our ...